Skip to main content
Download PDF

Screening and staging of chronic obstructive pulmonary disease with deep learning based on chest X-ray images and clinical parameters

BMC Pulmonary Medicine volume 24, Article number: 153 (2024) Cite this article

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is underdiagnosed with the current gold standard measure pulmonary function test (PFT). A more sensitive and simple option for early detection and severity evaluation of COPD could benefit practitioners and patients.

Methods

In this multicenter retrospective study, frontal chest X-ray (CXR) images and related clinical information of 1055 participants were collected and processed. Different deep learning algorithms and transfer learning models were trained to classify COPD based on clinical data and CXR images from 666 subjects, and validated in internal test set based on 284 participants. External test including 105 participants was also performed to verify the generalization ability of the learning algorithms in diagnosing COPD. Meanwhile, the model was further used to evaluate disease severity of COPD by predicting different grads.

Results

The Ensemble model showed an AUC of 0.969 in distinguishing COPD by simultaneously extracting fusion features of clinical parameters and CXR images in internal test, better than models that used clinical parameters (AUC = 0.963) or images (AUC = 0.946) only. For the external test set, the AUC slightly declined to 0.934 in predicting COPD based on clinical parameters and CXR images. When applying the Ensemble model to determine disease severity of COPD, the AUC reached 0.894 for three-classification and 0.852 for five-classification respectively.

Conclusion

The present study used DL algorithms to screen COPD and predict disease severity based on CXR imaging and clinical parameters. The models showed good performance and the approach might be an effective case-finding tool with low radiation dose for COPD diagnosis and staging.

Peer Review reports

Background

Chronic obstructive pulmonary disease (COPD) is a common pulmonary disease characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities mainly caused by cigarette smoking [1]. Despite many decades of research on the pathogenesis and treatment of COPD, the medical community has failed to decrease its morbidity and mortality to the same degree that has been achieved in other major noncommunicable diseases, An important factor contributing to this slow progress may be that he previous COPD definition showed limitations as the lack of identification of the disorder at its early stages in the absence of flow limitation [2]. The proposed solutions are aimed to encourage novel treatments and translational studies: incorporating into the definition objectivable early computed tomography (CT) scan changes [3]. Epidemiological studies have shown that COPD is the third leading cause of death and accounts for 5% of all deaths worldwide each year [4]. The overall prevalence of COPD in people aged 40 years and older was 12.64% (95% CI 10.75%-14.65%) and 7.38% [5]. About a quarter of adults over 40 years have moderate airflow limitations, yet most of them are unaware of their conditions [6]. Early diagnosis of COPD is critical for early self-management and timely therapy to improve the overall prognosis [7, 8]. However, a considerable proportion of COPD patients are undiagnosed. An estimate of over 40% of COPD patients remain undiagnosed, particularly in developing countries [9, 10], and only 12% of individuals with chronic airflow limitations had a previous spirometry-defined COPD diagnosis during the recent screening of 57,779 participants in China [11].

The conventional diagnosis and staging measure of COPD is pulmonary function test (PFT) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) diagnostic criteria [12]. However, spirometry strongly depends on patients’ cooperation and COPD can either be misdiagnosed or missed entirely when using spirometry alone [13]. The 2017 GOLD report recommended that therapy should be based on clinical criteria rather than isolated PFT [14]. Furthermore, due to the shortage of experienced spirometry experts in poor areas of developing countries, it’s hard to use PFT to screen asymptomatic patients in regular health examination on a large scale. Consequently, the need to develop new tools for early detection of COPD arises, and cost-effective strategies for case-finding are urgently needed.

In the past few years, growing evidences have shown that chest quantitative computer tomography (CT) has potential in COPD diagnosis and stratification [15,16,17,18]. CT-based imaging can help improve COPD detection and evaluation in patients who cannot undergo PFT [19]. In a recent study, deep learning (DL) models that utilize computed tomography (CT) image data were developed for automated detection and staging of spirometry-defined COPD. The result showed chest CT-DL approach could automatically identify spirometry-defined COPD and categorize patients according to the GOLD scale [11]. In the research reported by Lin Zhang, et al., they trained and tested the deep convolutional neural network (CNN) based on CT images of lung parenchyma and bronchial wall to determine the presence of COPD and GOLD staging, using PFT as reference, so as to infer lung function and determine the existence and severity of COPD. The result demonstrated that CNN can identify emphysema and airway wall remodeling on CT images to infer lung function and determine the existence and severity of COPD. As the CNN reached AUCs of 0.853 to determine the presence of COPD in the training and external test cohorts, and the accuracies of CNN to determine COPD GOLD grade in three- and five- classifications were 77.4 and 67.9%, respectively [20]. However, another recent study has shown that PFT results are not linearly correlated with CT lung attenuation areas in COPD patients [21], while the high radiation exposure is another important factor needed to be taken into account [22, 23]. The radiation exposure associated with CT has limited its use for COPD detection or frequent follow-up examinations to monitor disease progression [24]. Chest X-ray (CXR) is usually the first diagnostic tool used in evaluating patient’s lungs. Pulmonary emphysema is the main component of COPD characterized by permanent dilation of air spaces distal to terminal bronchioles [25]. Conventional CXR is commonly used to demonstrate the presence of emphysema in patients with suspected COPD [26,27,28]. It’s highly accurate for advanced emphysema [29], but only moderately sensitive in patients with mild to moderate emphysema [30,31,32]. Recently, machine learning (ML) technology is being assessed to perform medical tasks in almost every field of practice [33]. It has been successfully used in automated interpretation of PFT for differential diagnosis of obstructive lung diseases and COPD detection based on HRCT images [34,35,36]. However, none of the previous studies have used deep learning (DL) to predict COPD based on CXR images.

In the present study, we used DL algorithms to detect COPD and predict disease severity based on CXR imaging and clinical parameters, with the purpose to screen potential COPD patients while minimizing the need for additional radiographic examination. We hypothesized that applying DL algorithms to clinical and CXR imaging features would improve early diagnosis and prognosis prediction in COPD.

Methods

Study population

This was a multicenter retrospective study performed at the Third Affiliated Hospital of Sun Yat-sen University, the Third Affiliated Hospital of Sun Yat-sen University. Lingnan Hospital, the Six Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, and Huazhou Hospital of Traditional Chinese Medical. The data included frontal CXR images and clinical information of 1055 participants (535 patients with COPD and 520 controls) from outpatient, inpatient, and physical examination center settings between January 2019 and December 2021. This study was reviewed and approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University and requirements for written informed consent were waived due to the retrospective nature of the research.

Frontal images were identified by searching image databases for CXRs of the patients who also received PFT within one week, whereas lateral radiographs and oblique views were excluded. COPD diagnosis was confirmed by forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio less than 0.7 after inhalation of bronchodilators according to GOLD 2018. The severity of COPD is graded as GOLD 1 (FEV1%pred ≥ 80%), GOLD 2 (50%≤FEV1%pred < 80%), GOLD 3 (30%≤FEV1%pred < 50%), and GOLD 4 (FEV1%pred < 30%), as depending on the FEV1%pred value of PFT based on GOLD 2018. Since the diagnosis and severity of COPD depend on GOLD level based on PFT result, this study used the GOLD level as a reference standard to classify patients.

As COPD usually occurs in patients older than 40 years [6], all the subjects included in the present study were > 40 years old. The exclusion criteria were: (1) pregnant women; (2) other pulmonary diseases with abnormal CXR presentations, such as bronchiectasis, pulmonary fibrosis, atelectasis, pulmonary infectious disease, active pulmonary tuberculosis, pleural effusion, lung cancer, and pneumothorax; (3) severe renal insufficiency, severe liver disease, human immunodefciency virus, or other immune-related diseases; (4) previous chest surgery; (5) severe cardiac insufficiency; (6) in the acute phase of COPD. A total of 1224 subjects ranging in age from 41 to 86 years were recruited. Spirometry data, demographic information, smoking history, clinical indices and manifestations information were collected using a standardized data collection form. After excluding cases with incomplete clinical data (57 cases), substandard pulmonary function (42 cases), and poor CXR image quality (70 cases), finally 1055 participants were enrolled in the cohort. The 950 subjects recruited from the Third Affiliated Hospital of Sun Yat-sen University and the Third Affiliated Hospital of Sun Yat-sen University. Lingnan Hospital were randomly split into training set and internal test set, with a ratio of 70%:30% (Fig. 1). For the training set (n = 666), 49.4% were COPD patients (n = 329). Of the 284 subjects in internal test set, 49.3% (n = 140) were COPD patients. The 105 participants (66 COPD patients and 39 control subjects) from the Six Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, and Huazhou Hospital of Traditional Chinese Medical were used for external test set.

Demographic and clinical characteristics

A total of 1055 participants were finally included in the study: 535 COPD patients and 520 control subjects. The median age of COPD patients was higher than that of non-COPD participants (67 vs. 63, P < 0.001) and the majority of the COPD cohort was male (87.85%), which was consistent with COPD gender distributions in China [6]. A higher proportion of smokers (78.50% vs. 20.96%, P < 0.001), a reduced FEV1% (55.02% vs. 92.33%, P < 0.001), and a lower BMI (22.10 vs. 24.13, P = 0.001) were evident among COPD patients compared to control group. In addition, the symptoms of cough, sputum, and dyspnea were more common in COPD patients than in control subjects (77.94%, 51.40%, 50.47% vs. 13.46%, 8.46%, 2.31%, respectively). The percentages of stage 1, 2, 3, and 4 spirometry-defined COPD subjects on the GOLD scale were 18.50%, 42.06%, 25.61%, and 13.83%, respectively. Detailed demographic and clinical characteristics for the participants were provided in Table 1.

Table 1 Demographic and clinical characteristics
Full size table

Data preprocessing

The data set consisted of clinical information and CXR images. The clinical information contained nine characteristics in all: gender, age, average body mass index (BMI), history of smoking, cough, expectoration, carbon dioxide retention, (arterial partial pressure of carbon dioxide greater than 45mmHg), dyspnea, respiratory failure (arterial partial oxygen pressure less than 60mmHg, with or without elevated carbon dioxide levels) and so on. Identity information including patient’s name, hospitalization ID and other DICOM information were removed from CXR images. In two classifications, the data were divided into normal control subjects without COPD (n = 520) and patients with COPD (n = 535). In three-classifications, the data were divided into three groups, normal (n = 520), GOLD 1/2 (n = 318), and GOLD 3/4 (n = 217), while in five-classifications, the data were divided into five groups, including normal (n = 520), GOLD 1 (n = 99), GOLD 2 (n = 225), GOLD 3 (n = 137), and GOLD 4 (n = 74).

Development of the COPD detection and COPD staging model

We first studied the comparison between normal control subjects and patients with COPD based on clinical data only. Clinical information were preprocessed through sk-learn’s data preprocessing interface StandardScaler, by filling in the missing values and standardizing the data to (-1, 1) interval. Three classical machine learning algorithms, decision tree, support vector machine and random forest were selected for modeling. The random forest algorithm showing best area under the curve (AUC) was determined to be the best algorithm for feature mining and extraction of clinical inform clinical information. For classification of CXR images, we generally chose transfer learning for modeling. Three classical deep learning convolution neural networks such as EfficientNet-B5, ResNet50 and DenseNet were selected for modeling [37,38,39]. The EfficientNet-B5 algorithm showing best AUC was determined to be the best algorithm for feature extraction of CXR images.

As referred to a previous study [40], we next input the clinical information into the random forest model and synchronously input CXRs input the EfficientNe-B5 model to get the corresponding prediction probability values of the two modal data. Finally, the two prediction probability values were averaged to get the final prediction value. This kind of model which combined the features of the clinical information model with the features of the image model was called Ensemble model. Based on the Ensemble model algorithm for simultaneous extraction of text and images, we were able to make more comprehensive use of data and diagnose more accurately. Finally, the Ensemble model was used to model three-classification and five-classification problems as well (as shown in Fig. 1).

Fig. 1
figure 1

Diagram of the study procedure. (A) The inclusion and exclusion flow chart of the dataset; (B) Flowchart for proposed COPD detection and staging prediction model. Deep learning models were trained to classify COPD based on CXR images or clinical features only. The best two models were selected and mixed as a new model for simultaneously extracting clinical data and CXR images to identify COPD. COPD, chronic obstructive pulmonary disease; GOLD, the global initiative for chronic obstructive lung disease; PEF, pulmonary function test; CXR, chest X-ray; BMI, body mass index; AUC, area under the curve

Full size image

Statistical analysis

Measurement data with normal distribution were presented as mean ± standard deviation (SD), which can reflect the overall trend and degree of variation, while data with non-normal distribution were presented as the median (M) and upper and lower quartile spacing (IQR), not affected by extreme values. Categorical variables were presented as numbers (%). The Wilcoxon signed-rank or Kruskal-Wallis tests were used for numerical variables, because they are non-parametric tests and suitable for quantitative data with non-normal distribution and do not need to satisfy normality. Fisher exact tests were used for categorical variables, and it is sensitive to small sample sizes. Statistical analysis was performed using the IBM SPSS statistics 20.0 software (SPSS). For two-way classification, the threshold of CNN-derived confidence was determined by the maximum value of AUC. The confidence threshold is determined by AUC maximization, which can achieve the best precision and recall ratio balance. The diagnostic performance of CNN was evaluated by AUC, accuracy, sensitivity, specificity, and F1 score. F1 score is the harmonic average of model accuracy and recall in machine learning. These indexes can be used to evaluate the application value of CNN model.

Results

Determining the presence of COPD

Of the three machine learning algorithms used to classify COPD based on clinical information only, the random forest algorithm showed best performance for detecting COPD in the internal test set, with an AUC of 0.963, while the sensitivity, specificity, NPV, PPV, and F1 score were 0.940, 0.880, 0.940, 0.890 and 0.910, respectively. The Random Forest improves generalization ability through ensemble learning and utilizes randomness and multiple decision trees to increase robustness against noise, making it more suitable for clinical information classification problems with limited samples and complex distributions, thus outperforming SVM and a single decision tree. When using deep learning to predict COPD only based on CXR images, the EfficientNet-B5 algorithm exhibited relatively robust performance, with an AUC of 0.946. The EfficientNet achieves the best balance among accuracy, parameter amount, and computational cost through automated neural architecture search, efficient network module design, extensive data augmentation and optimization techniques, making it outperform ResNet and DenseNet on image classification tasks.

We subsequently applied Ensemble model to distinguish COPD by simultaneously extracting fusion features of clinical parameters and CXR images. The model showed an AUC of 0.969, slightly higher than better than that used clinical parameters or images only. We further incorporated Friedman’s statistical test and post hoc multiple comparisons into the analysis for more accurate comparison between these differences referring to the methods used in the previous studies [41, 42]. Friedman test was performed using the scipy library, resulting in a Friedman Statistic of 9.851 and a corresponding p-value of 0.00725, indicating significant differences among the groups. Subsequently, post hoc multiple comparisons were conducted using the scikit-posthocs library, specifically employing the Nemenyi test to discern specific group differences. The significance level between random forest and Ensemble is relatively high, suggesting that the differences between them are not highly significant. However, the significance levels between EfficientNet and Ensemble, as well as between EfficientNet and random forest, are relatively low, indicating significant differences between these pairs. It indicated that the Ensemble model simultaneously extracting fusion features of clinical parameters and CXR images could make more comprehensive use of data and diagnose more accurately (Fig. 2). Other measurements, including sensitivity, specificity, PPV, NPV, and F1 score were 0.960, 0.860, 0.870, 0.960 and 0.920 respectively, as summarized in Table 2.

Table 2 Prediction performance of DL models for COPD based on CXR images and clinical data in internal test
Full size table

External test was further performed with the Ensemble model to verify the generalization ability of the learning algorithms in diagnosing COPD. It showed an AUC of 0.934 in COPD prediction based on the external test set, just slightly declined compared to that in internal test (Fig. 2).

Fig. 2
figure 2

COPD detection performance of deep Learning models in two-classifications. AUC of COPD prediction based on clinical data (A) and CXR images (B) respectively in internal test; AUC for detecting COPD based on clinical data and CXR images simultaneously in internal test (C); AUC of COPD prediction based on clinical data and CXR images by Ensemble model in external test (D). AUC, area under the curve; COPD, chronic obstructive pulmonary disease; GOLD, the global initiative for chronic obstructive lung disease; CXR, chest X-ray

Full size image

Prediction performance of COPD staging

We next used the Ensemble model to evaluate disease severity of COPD by predicting different GOLD stages according to clinical data and CXR images. For three-classification, the AUC reached 0.894 and the accuracy was 0.79 (shown in Fig. 3). In five-classification model, the AUC value slightly declined to 0.852, with an accuracy of 0.52 (eTable 1).

Fig. 3
figure 3

GOLD stage prediction performance of the Ensemble model based on CXR images and clinical data. (A). AUC of COPD stage prediction for the Ensemble model in two, three and five-classifications. Confusion matrices of the Ensemble model to evaluate COPD stage in three (B) and five-classifications (C). GOLD, the global initiative for chronic obstructive lung disease; COPD, chronic obstructive pulmonary disease; AUC, area under the curve

Full size image

Interpretability of clinical information and feature extraction visualization

Through the feature importance interface of random forest, we could rank the importance of 9 kinds of clinical information to model decision-making in ascending order. For two classifications, three classifications and five classifications, different weight distribution maps were shown in Fig. 4 respectively.

Fig. 4
figure 4

Weight distribution maps for interpretability of clinical information in COPD detection (A), stage prediction in three-classifications (B), and five-classifications (C) respectively. COPD, chronic obstructive pulmonary disease; GOLD, the global initiative for chronic obstructive lung disease; BMI, body mass index

Full size image

Gradient-weighted class activation mapping (Grad-CAM) was applied to visualize feature extraction by using a heatmap, the main signature lesions related to COPD detection in CXR images, such as emphysema was manifest as increased values in the GradCAM results (eFigure 1 in the supplement).

Discussion

In this multicenter retrospective study, we used deep learning algorithms to predict COPD based on clinical parameters and CXR images, with the purpose to find a more sensitive and simple option for early detection of potential COPD patients. The diagnostic accuracies of COPD reached an AUC of 0.965 in internal test and 0.934 in external test to detect COPD according clinical characteristics and CXR images, better than the results of previous study, which used deep residual networks for automated detection of COPD based on low dosed CT images only, with an ACU of 0.889 [4] and 0.899 [20], respectively. The DL models also retained high accuracies in determining COPD grade in three-and five-classifications, showed an AUC of 0.894 and 0.79 respectively. It indicated that the algorithms had considerable potential to screen suspected COPD patients, which would help early diagnosis of the disease and subsequently increase the rate of smoking cessation and preventive treatment, so as to improve prognosis of COPD.

As we know, the diagnosis of COPD mainly depends on PFT. However, its accuracy is highly dependent on the patient’s cooperation, which explains the common under and over diagnosis of COPD in clinical practice [35, 43]. To address this challenge, recently some other methods have been considered to be useful in early screening of COPD as rapid advance on ML technology [44]. Chest CT has also been widely used to detect lung texture abnormalities and assess the state of COPD [45, 46]. In a recent prospective study, the pulmonary ventilation function of COPD was assessed by analyzing chest CT images, with an accuracy of 88% and an AUC value of 0.82 [47]. In another study, DL models that utilize CT image for detection and staging of COPD achieved an AUC of 0.934 on the internal test set and 0.866 on the external test [11]. These studies indicated better performance of DL based on CT images. However, proper selection and capture of target images of a large amount of image data is still a question to be resolved even with the help of ML, while high radiation exposure may also limit the use of CT for early screening of COPD.

To develop a more simple and effective method for COPD detection, we focused on conventional CXR imaging. This method is economical and safe but rarely been used for COPD detection due to insensitivity, which, however, can be overcome with the help of DL. As expected, the AUC achieved 0.946 on detecting COPD, approximated to the AUC of 0.934 that achieved by DL models used CT images and clinical information [11], and better that the result of another study published by Tang LYW, which used deep residual networks for automated detection of COPD based on low dosed CT images only, with an ACU of 0.889 [7]. It indicated that the DL model based on CXR images was able to perform well in COPD screening. According to the guideline of GOLD, diagnosis of COPD should be made based on symptoms meanwhile. The clinical parameters, such as symptoms and smoking history, are equally important in diagnosis of COPD [12, 48]. Thus, to increase the sensitivity of models, clinical parameters including demographic data, symptoms and examination results were combined with CXR images for assessment in this study. Consequently, the AUC rise to 0.969, higher than that used clinical parameters (0.963) or CXR images (0.946) only. What’s more, the model kept good performance even in external test (with an AUC of 0.943). This might help our algorithm better generalize to detection of COPD in patients without significant airflow limitations.

The weight distribution maps showed that different parameters accounted different importance in decision-making. Of which, type 2 respiratory failure and CO2 retention ranked in the bottom as the least two important factors in predicting COPD. This was not in consistence with the situation in clinical practice, as the two situation above were mostly seen in sever COPD patients. The possible explanation might be that the COPD patients included in the present study were mainly mild to moderate, who rarely had CO2 retention or type II respiratory failure. Only 11.51% patients had CO2 retention and 5.76% showed type II respiratory failure. As a result, it seemed like that the two parameters above accounted not so important in decision-making of predicting COPD consequently. However, when the same model was used to evaluate disease severity, the weight distribution of them increased in three- and five- classifications as they were quite common manifestation for sever patients of GOLD stage 3 or 4.

Cough and dyspnea are most common symptoms of COPD, and smoking is the most important cause. They also played critical roles in discriminating COPD patients from control subjects, and ranked the top three on the decision-making weight distribution map, just as respected. Nevertheless, when the Ensemble model was applied to predict disease stages, e.g., in five-classifications, the two leading parameters in decision-making changed to BMI and age, suggesting that they contributed more important in assessing disease severity. As we know, BMI and age are closely correlated to pulmonary function. As the age advances, the pulmonary function gets worse, while BMI is usually positively correlated to pulmonary function. Weight loss and decreased BMI seem to be more common in severer COPD patients such as patients with GOLD stage 3 or 4.

One of the common problems seen in DL algorithm is the “black box” nature of the DL model, which may greatly limit its use in clinical situations, as it does not provide sufficient information for clinicians concerning its decision-making process. Yet the lack of transparency in machine learning can be overcome by applying gradient-weighted class activation mapping (Grad-CAM) to visualize feature extraction using a heatmap [49]. Through the gradcam interface of the EfficientNet model, we can get the hot focus areas of the CNN model for the diagnosis of COPD patients. The results indicated that the model paid specific attention to these lesions when distinguishing COPD subjects. This could make doctors and patients better understand what they have learned from DL, and whether they can rest assured that ML can assist them in diagnosis.

There are several limitations in the present study. First, this was a retrospective study only performed in four medical institutes. The outer generalization of the deep learning algorithms needed to be tested further by prospective study including more centers. Second, the prediction was performed based on COPD and normal control. Subjects involved in the present study were mainly COPD patients without other complications or disease, as radiographic images with other lesion were eliminated. For better use in clinical practice, subsequent study with larger sample size including complication or comorbidities of COPD is needed. Third, a limited number of subjects with GOLD 1 and 4 were enrolled, which might constrain the model’s stratification capacity and resulted in the discrepancy of staging efficiency between groups. To improve the efficiency of detection and staging, we are currently recruiting more participants and aim to optimize our cohort in the future.

In conclusion, we developed a more simple, sensitive and safer learning approach for detecting and staging of COPD. The proposed model approach achieved the desired performance and could serve as a powerful tool for COPD screening and evaluation, which may help clinicians easily identify possible suspected COPD patients. Nevertheless further studies are necessary to determine the feasibility of these outcomes in a prospective clinical setting.

Data availability

The datasets generated and analysed during the current study are not publicly available due for protection of participants’ privacy, but are available from the corresponding author on reasonable request.

Abbreviations

COPD:

Chronic obstructive pulmonary disease

PFT:

pulmonary function test

GOLD:

Global Initiative for Chronic Obstructive Lung Disease

CT:

computed tomography

CXR:

chest X-ray

ML:

machine learning

DL:

deep learning

FEV1:

forced expiratory volume in 1 s

FVC:

forced vital capacity

BMI:

body mass index

SD:

standard deviation

AUC:

area under the curve

CO2:

carbon dioxide

ACC:

accuracy

PPV:

positive predictive value

NPV:

negative predictive value

F1:

false positive rate

Grad-CAM:

Gradient-weighted class activation mapping

References

  1. Bakker JT, Klooster K, Vliegenthart R, et al. Measuring pulmonary function in COPD using quantitative chest computed tomography analysis. Eur Respir Rev. 2021;30:210031.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Confalonieri M, Braga L, Salton F, Ruaro B, Confalonieri P. Chronic obstructive Pulmonary Disease Definition: is it time to incorporate the Concept of failure of lung regeneration? Am J Respir Crit Care Med. 2023;207(3):366–7.

    Article  PubMed  Google Scholar 

  3. Celli B, Fabbri L, Criner G, et al. Definition and nomenclature of Chronic Obstructive Pulmonary Disease: time for its revision. Am J Respir Crit Care Med. 202;206(11):1317–25.

  4. World Health Organization. The top 10 causes of death. www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death Date last updated: 9 December 2020.

  5. Al Wachami N, Guennouni M, Iderdar Y, et al. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMC Public Health. 2024;24(1):297.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706–17.

    Article  PubMed  Google Scholar 

  7. Tang LYW, Coxson HO, Lam S, et al. Towards large-scale case-finding: training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT. Lancet Digit Health. 2020;2:e259–67.

    Article  PubMed  Google Scholar 

  8. Labaki WW, Han MK. Improving detection of early chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15:S243–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Perez-Padilla R, Thirion-Romero I, Guzman N. Underdiagnosis of chronic obstructive pulmonary disease: should smokers be offered routine spirometry tests? Expert Rev Respir Med. 2018;12:83–5.

    Article  CAS  PubMed  Google Scholar 

  10. Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–85.

    Article  PubMed  Google Scholar 

  11. Sun J, Liao X, Yan Y, et al. Detection and staging of chronic obstructive pulmonary disease using a computed tomography–based weakly supervised deep learning approach. Eur Radiol. 2022;32:5319–29.

    Article  PubMed  Google Scholar 

  12. Fischer AM, Varga-Szemes A, Martin SS, et al. Artificial Intelligence-based fully automated per lobe segmentation and emphysema-quantificationmbased on chest computed Tomography compared with Global Initiative for Chronic Obstructive Lung Disease severity of smokers. J Thorac Imaging. 2020;35:S28–34.

    Article  PubMed  Google Scholar 

  13. Miller MR, Levy ML. Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ. 2015;351:h3021.

    Article  PubMed  Google Scholar 

  14. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195:557–82.

    Article  CAS  PubMed  Google Scholar 

  15. Labaki WW, Martinez CH, Galbàn CG, et al. The role of chest CT in the evaluation and management of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196:1372–9.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lynch DA, Moore CM, Wilson C, et al. CT-based visual classification of emphysema: association with mortality in the COPDGene study. Radiology. 2018;288:859–66.

    Article  PubMed  Google Scholar 

  17. Bhatt SP, Washko GR, Hoffman EA et al. Imaging advances in chronic obstructive pulmonary disease. Insights from the genetic epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) study. Am J Respir Crit Care Med 199:286–301.

  18. Park J, Hobbs BD, Crapo JD, et al. Subtyping COPD by using visual and quantitative CT imaging features. Am J Respir Crit Care Med. 2019;199:286–301.

    Google Scholar 

  19. Castillo-Saldana D, Hague CJ, Coxson HO, et al. Using quantitative computed tomographic imaging to understand chronic obstructive pulmonary disease and fibrotic interstitial lung disease: state of the art and future directions. J Thorac Imaging. 2020;35:246–54.

    Article  PubMed  Google Scholar 

  20. Zhang L, Jiang B, Wisselink HJ, Vliegenthart R, Xie X. COPD identification and grading based on deep learning of lung parenchyma and bronchial wall in chest CT images. Br J Radiol. 2022;95(1133):20210637.

    Article  PubMed  Google Scholar 

  21. Paoletti M, Cestelli L, Bigazzi F, et al. Chronic obstructive pulmonary disease: pulmonary function and CT lung attenuation do not show linear correlation. Radiology. 2015;276:571–8.

    Article  PubMed  Google Scholar 

  22. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008;248:254–63.

    Article  PubMed  Google Scholar 

  23. Larke FJ, Kruger RL, Cagnon CH, et al. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. AJR Am J Roentgenol. 2011;197:1165–9.

    Article  PubMed  Google Scholar 

  24. Willer K, Fingerle AA, Noichl W, et al. X-ray dark-field chest imaging for detection and quantification of emphysema in patients with chronic obstructive pulmonary disease: a diagnostic accuracy study. Lancet Digit Health. 2021;3:e733–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. den Harder AM, de Boer E, Lagerweij SJ, et al. Emphysema quantification using chest CT: influence of radiation dose reduction and reconstruction technique. Eur Radiol Exp. 2018;2:30.

    Article  Google Scholar 

  26. Cavigli E, Camiciottoli G, Diciotti S, et al. Whole-lung densitometry versus visual assessment of emphysema. Eur Radiol. 2009;19:1686–92.

    Article  PubMed  Google Scholar 

  27. Singla S, Gong M, Riley C, et al. Improving clinical disease subtyping and future events prediction through a chest CTbased deep learning approach. Med Phys. 2021;48:1168–81.

    Article  PubMed  Google Scholar 

  28. Goldin JG. Imaging the lungs in patients with pulmonary emphysema. J Thorac Imaging. 2009;24:163–70.

    Article  PubMed  Google Scholar 

  29. Miniati M, Monti S, Stolk J, et al. Value of chest radiography in phenotyping chronic obstructive pulmonary disease. Eur Respir J. 2008;31:509–15.

    Article  CAS  PubMed  Google Scholar 

  30. Washko GR. Diagnostic imaging in COPD. Semin Respir Crit Care Med. 2010;31:276–85.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Meinel FG, Schwab F, Schleede S, et al. Diagnosing and mapping Pulmonary Emphysema on X Ray Projection images: Incremental Value of Grating Based X-Ray Dark-Field Imaging. PLoS ONE. 2013;8:e59526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hellbach K, Yaroshenko A, Meinel FG, et al. In vivo dark-field radiography for early diagnosis and staging of pulmonary emphysema. Invest Radiol. 2015;50:430–5.

    Article  PubMed  Google Scholar 

  33. Rajkomar A, Dean J, Kohane I. Machine learning in Medicine. N Engl J Med. 2019;380:1347–58.

    Article  PubMed  Google Scholar 

  34. Das N, Topalovic M, Janssens W. Artificial intelligence in diagnosis of obstructive lung disease: current status and future potential. Curr Opin Pulm Med. 2018;24:117–23.

    Article  PubMed  Google Scholar 

  35. Topalovic M, Laval S, Aerts J-M, et al. Automated interpretation of pulmonary function tests in adults with respiratory complaints. Respiration. 2017;93:170–8.

    Article  PubMed  Google Scholar 

  36. González G, Ash SY, Vegas-Sánchez-Ferrero G, et al. Disease staging and prognosis in smokers using deep learning in chest computed tomography. Am J Respir Crit Care Med. 2018;197:193–203.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Huang G, Liu Z, Pleiss G, Maaten LV, Weinberger KQ. Convolutional Networks with dense connectivity. IEEE Trans Pattern Anal Mach Intell. 2022;44(12):8704–16.

    Article  PubMed  Google Scholar 

  38. He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. arXiv:1512.03385.

  39. Tan M, Quoc V, Le. EfficientNet: rethinking Model scaling for convolutional neural networks. arXiv:1905.11946.

  40. Chandra TB, Singh BK, Jain D. Integrating patient symptoms, clinical readings, and radiologist feedback with computer-aided diagnosis system for detection of infectious pulmonary disease: a feasibility study. Med Biol Eng Comput. 2022;60(9):2549–65.

    Article  PubMed  Google Scholar 

  41. Chandra TB, Singh BK, Jain D. Disease localization and Severity Assessment in chest X-Ray images using Multi-stage superpixels classification. Comput Methods Programs Biomed. 2022;222:106947.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Chandra TB, Verma K, Singh BK, Jain D, Netam SS. Coronavirus disease (COVID-19) detection in chest X-Ray images using majority voting based classifier ensemble. Expert Syst Appl. 2021;165:113909.

    Article  PubMed  Google Scholar 

  43. Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198:1130–9.

    Article  PubMed  Google Scholar 

  44. Feng Y, Wang Y, Zeng C, et al. Artificial Intelligence and Machine Learning in Chronic Airway diseases: Focus on Asthma and Chronic Obstructive Pulmonary Disease. Int J Med Sci. 2021;18:2871–89.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Xu C, Qi S, Feng J, et al. DCT-MIL: Deep CNN transferred multiple instance learning for COPD identification using CT images. Phys Med Biol. 2020;65:145011.

    Article  PubMed  Google Scholar 

  46. Matsumura K, Ito S. Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach. BMC Pulm Med. 2020;20(1):29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Westcott A, Capaldi D, McCormack DG, et al. Chronic obstructive Pulmonary Disease: Thoracic CT Texture Analysis and Machine Learning to Predict Pulmonary Ventilation. Radiology. 2019;293:676–84.

    Article  PubMed  Google Scholar 

  48. Andreeva E, Pokhaznikova M, Lebedev A, et al. Spirometry is not enough to diagnose COPD in epidemiological studies: a follow-up study. NPJ Prim Care Respir Med. 2017;27:62.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Esteva A, Robicquet A, Ramsundar B, et al. A guide to deep learning in healthcare. Nat Med. 2019;25:24–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by National Key Technology R&D Program (2018YFC1311900) and Shenzhen Science and Technology Program (No. JCYJ20220530145001002).

Author information

Author notes

  1. These authors contributed equally to the study.

Authors and Affiliations

  1. Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Institute of Respiratory Diseases of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China

    XiaoLing Zou, HaiLing Yang, LiYi Zhang, WenWen Ding & TianTuo Zhang

  2. Scientific research project department, Guangdong Artificial Intelligence and Digital Economy Laboratory (Guangzhou), Pazhou Lab, Guangzhou, China

    Yong Ren

  3. Shensi lab, Shenzhen Institute for Advanced Study, UESTC, Shenzhen, China

    Yong Ren

  4. Department of Pulmonary and Critical Care Medicine, Dongguan People’s Hospital, Dongguan, China

    ManMan Zou

  5. Department of Pulmonary and Critical Care Medicine, the Six Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, China

    Ping Meng

  6. Department of Internal Medicine, Huazhou Hospital of Traditional Chinese Medicine, Huazhou, China

    MingJuan Gong

  7. Center for artificial intelligence in medicine, Research Institute of Tsinghua, Pearl River Delta, Guangzhou, China

    LanQing Han

Authors
  1. XiaoLing Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. HaiLing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. ManMan Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ping Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. LiYi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. MingJuan Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. WenWen Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. LanQing Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. TianTuo Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TianTuo Zhang and LanQing Han had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. XiaoLing Zou, Yong Ren and HaiLing Yang equally contributed to this work.Concept and design: XiaoLing Zou, Yong Ren, HaiLing YangAcquisition, analysis, or interpretation of data: Yong Ren, HaiLing Yang, ManMan Zou, Ping Meng, LiYi Zhang, MingJuan Gong, WenWen DingStatistical analysis: XiaoLing Zou, Yong Ren, HaiLing YangAdministrative, technical, or material support: XiaoLing Zou, Yong Ren, HaiLing Yang, TianTuo Zhang, LanQing Han Drafting of the manuscript: XiaoLing Zou, Yong RenSubmission of the study: XiaoLing ZouSupervision: TianTuo Zhang, LanQing Han.

Corresponding authors

Correspondence to LanQing Han or TianTuo Zhang.

Ethics declarations

Ethics approval and consent to participate

This study was reviewed and approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University. The need for informed consent was waived by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

TianTuo Zhang and LanQing Han contributed to this work as corresponding authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zou, X., Ren, Y., Yang, H. et al. Screening and staging of chronic obstructive pulmonary disease with deep learning based on chest X-ray images and clinical parameters. BMC Pulm Med 24, 153 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s12890-024-02945-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12890-024-02945-7

Keywords

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us